Logo image
Pharmacological Plus Optical Penalization Treatment for Amblyopia Results of a Randomized Trial
Journal article   Open access

Pharmacological Plus Optical Penalization Treatment for Amblyopia Results of a Randomized Trial

Susan A. Cotter, David R. Weakley, Samara F. Strauber, Roy W. Beck, Eileen E. Birch, Sean Donahue, Jonathan M. Holmes, Darren L. Hoover, Pamela A. Huston, B. Michele Melia, …
Archives of ophthalmology (1960), v 127(1), pp 22-30
01 Jan 2009
PMID: 19139333
url
https://europepmc.org/articles/pmc2713107View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Life Sciences & Biomedicine Ophthalmology Science & Technology
Objective: To compare weekend atropine sulfate use augmented by a plano lens for the sound eye with weekend atropine use alone for moderate amblyopia in children aged 3 years to younger than 7 years. Methods: In a multicenter clinical trial, 180 children with moderate amblyopia (visual acuities of 20/40-20/100) were randomized to weekend atropine use augmented by a plano lens or weekend atropine use alone. Main Outcome Measure: Masked assessment of amblyopic eye visual acuity using the Amblyopia Treatment Study HOTV testing protocol at 18 weeks. Results: At 18 weeks, amblyopic eye improvement averaged 2.8 lines in the group that received atropine plus a plano lens and 2.4 lines in the group that received atropine alone (mean difference between groups adjusted for baseline acuity, 0.3 line; 95% confidence interval, -0.2 to 0.8 line). Amblyopic eye visual acuity was 20/25 or better in 24 patients (29%) in the group that received atropine only and 35 patients (40%) in the group that received atropine plus a plano lens (P = .03). More patients in the group that received atropine plus a plano lens had reduced sound eye visual acuity at 18 weeks; however, there were no cases of persistent reverse amblyopia. Conclusions: As an initial treatment for moderate amblyopia, the augmentation of weekend atropine use with a plano lens does not substantially improve amblyopic eye visual acuity when compared with weekend atropine use alone. Application to Clinical Practice: Treatment of children with unilateral amblyopia. Trial Registration: clinicaltrials.org Identifier: NCT00315302

Metrics

8 Record Views
57 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Ophthalmology
Logo image